Technical Ventures RX Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Technical Ventures RX General Information
Description
Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.
Contact Information
Corporate Office
- 1015 - 4 Street SouthWest
- Suite 730
- Calgary, Alberta T2R 1J4
- Canada
Corporate Office
- 1015 - 4 Street SouthWest
- Suite 730
- Calgary, Alberta T2R 1J4
- Canada
Technical Ventures RX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Technical Ventures RX Acquisitions (1)
Technical Ventures RX’s most recent deal was a Reverse Merger with Hemostemix. The deal was made on 10-Nov-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hemostemix | 10-Nov-2014 | Reverse Merger | Biotechnology |
Technical Ventures RX FAQs
-
When was Technical Ventures RX founded?
Technical Ventures RX was founded in 2012.
-
Where is Technical Ventures RX headquartered?
Technical Ventures RX is headquartered in Calgary, Canada.
-
What industry is Technical Ventures RX in?
Technical Ventures RX’s primary industry is Special Purpose Acquisition Company (SPAC).
-
Is Technical Ventures RX a private or public company?
Technical Ventures RX is a Private company.
-
What is Technical Ventures RX’s current revenue?
The current revenue for Technical Ventures RX is .
-
How much funding has Technical Ventures RX raised over time?
Technical Ventures RX has raised $303K.
-
When was Technical Ventures RX acquired?
Technical Ventures RX was acquired on 12-Nov-2014.
-
Who acquired Technical Ventures RX?
Technical Ventures RX was acquired by Hemostemix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process